CS261699B1 - 6-Amino-2-n-pentylthiobenzothiazole - Google Patents
6-Amino-2-n-pentylthiobenzothiazole Download PDFInfo
- Publication number
- CS261699B1 CS261699B1 CS879176A CS917687A CS261699B1 CS 261699 B1 CS261699 B1 CS 261699B1 CS 879176 A CS879176 A CS 879176A CS 917687 A CS917687 A CS 917687A CS 261699 B1 CS261699 B1 CS 261699B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- amino
- yeast
- compound
- pentylthiobenzothiazole
- mercaptobenzothiazole
- Prior art date
Links
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Predmetom riešenia je doteraz neznámy 6-amíno-2-n-pentyltiobenzotiazol vzorca C-S N Ch?ch? ktorý sa připravuje alkylácíou draselnej soli 6-ainíno-2-merkaptobenzotiazolu n-pentyljodidom v zmesi dimetylformamidu, alebo dimetylsulfoxidu s vodou. Zlúčenina je antifungálne účinná proti kvasinkám, a to aj proti patogénnym, a inhibuje transformáciu kvasinkovitej formy patogénnych dimorfných kvasiniek na myceliárnu formu. Zlúčeninu možno používat ako účinnú zložku protikvasinkových přípravkov (antimykotík) alebo ako medziprodukt pre ďalšie syntézy.The subject of the solution is the hitherto unknown 6-amino-2-n-pentylthiobenzothiazole of the formula C-S N Ch?ch? which is prepared by alkylating the potassium salt of 6-amino-2-mercaptobenzothiazole with n-pentyl iodide in a mixture of dimethylformamide or dimethyl sulfoxide with water. The compound is antifungally effective against yeasts, including pathogenic ones, and inhibits the transformation of the yeast-like form of pathogenic dimorphic yeasts into the mycelial form. The compound can be used as an effective component of anti-yeast preparations (antifungals) or as an intermediate for further syntheses.
Description
Predmetom riešenia je doteraz neznámy 6-amíno-2-n-pentyltiobenzotiazol vzorcaThe subject of the solution is the previously unknown 6-amino-2-n-pentylthiobenzothiazole of the formula
C-SC-S
Ch?ch?Ch?ch?
ktorý sa připravuje alkylácíou draselnej soli 6-ainíno-2-merkaptobenzotiazolu n-pentyljodidom v zmesi dimetylformamidu, alebo dimetylsulfoxidu s vodou. Zlúčenina je antifungálne účinná proti kvasinkám, a to aj proti patogénnym, a inhibuje transformáciu kvasinkovitej formy patogénnych dimorfných kvasiniek na myceliárnu formu. Zlúčeninu možno používat ako účinnú zložku protikvasinkových přípravko v (antimykotík) alebo ako medziprodukt pre ďalšie syntézy.which is prepared by alkylation of the potassium salt of 6-amino-2-mercaptobenzothiazole with n-pentyl iodide in a mixture of dimethylformamide or dimethyl sulfoxide with water. The compound is antifungally active against yeasts, including pathogenic ones, and inhibits the transformation of the yeast-like form of pathogenic dimorphic yeasts into the mycelial form. The compound can be used as an active ingredient in anti-yeast preparations (antifungals) or as an intermediate for further syntheses.
2S12S1
Predmetom vynálezu je 6-amíno-2-n-pentyltlobenzotíazol. 2-alkyltio-6-amínobenzotiazoly prejavili dobrá antimykobakteriálnu účinnosť, najma proti atypickým kmeňom tuberkulóznych mykobaktérií [Sidóová, E., Odletová Z., Volná F. a Blockinger G., Chem.The subject of the invention is 6-amino-2-n-pentylthiobenzothiazole. 2-alkylthio-6-aminobenzothiazoles have shown good antimycobacterial activity, especially against atypical strains of tuberculous mycobacteria [Sidóová, E., Odletová Z., Volná F. and Blockinger G., Chem.
Zvěsti 33, 830 (1979), Sidóová E. a Odlerová Ž., čsl. AO 189 212 (1978) J, pre obtiažnu izoláciu však neboli všetky deriváty izolované v čistom stave.Zvesti 33, 830 (1979), Sidóová E. and Odlerová Ž., Czechoslovak AO 189 212 (1978) J, however, due to difficult isolation, not all derivatives were isolated in the pure state.
Teraz bolo zistené, že doteraz neznáma zlúčenina vzorcaIt has now been discovered that a previously unknown compound of the formula
CHZ Ch£ CH2 Ch3 je protiikvasinkovo účinná proti Candida albicans, Saccharomyces cerevisiae, ako aj proti niektorým patogénnym kvasinkám. CH Z Ch £ CH 2 Ch 3 is anti-yeast effective against Candida albicans, Saccharomyces cerevisiae, as well as against some pathogenic yeasts.
Súčasne bol zistený sposob přípravy uvedenej zlúčeniny na báze 6-amíno-2-benzotiazolíntiónu jiným názvom 6-amíno-2-merkaptobenzotiazolu), tým spQsobom, že draselná sol1 6-amíno-2-merkaptobenzotiazolu sa alkyluje n-pentyljodidom v prostředí zmesi dimetylformamidu s vodou, alebo dimetylsulfoxldu s vodou.At the same time, a method of preparing the above-mentioned compound based on 6-amino-2-benzothiazolinethione (also known as 6-amino-2-mercaptobenzothiazole) was discovered by alkylating the potassium salt of 6-amino-2-mercaptobenzothiazole with n-pentyl iodide in a mixture of dimethylformamide with water or dimethylsulfoxide with water.
Nasledujúce příklady bližšie osvetíujú, ale nijako neobmedzujú přípravu a vlastnosti zlúčeniny podlá vynálezu.The following examples illustrate, but do not limit, the preparation and properties of the compounds of the invention.
Příklad 1Example 1
Příprava 6-amíno-2-n-pentyltiohenzotiazoluPreparation of 6-amino-2-n-pentylthiohenzothiazole
6-ammo-2-benzotiazolíntión (27,3 g, 0,15 molu) sa rozpustí v roztoku hydroxidu draselného (9,9 g, 0,15 molu) vo vodě (50 cm3). K reakčnej zmesi sa za intenzívneho miešania přidá dimetylformamid (125 cm3) a len čo vznikol homogénny roztok, prllial sa k reakčnej zmesi v jednej dávke n-pentyljodid (29,7 g, 0,15 molu). V intenzívnom miešaní sa pokračovalo 30 minút, potom sa zmes vyliala na lad (1 500 g) a odstavila. Po stáhnutí sa surový produkt odsál a ešte za mokra sa rozotieral s niekolkými dávkami petroléteru (spolu 300 cm3), pričom sa vodný petroléter zakaždým dekantoval. Tuhý zbytok sa rozpustil za varu v acetone, k roztoku sa přidala voda do prvého slabého zákalu a zmes sa odfarbila aktívnym uhlím. Filtrát po vychladnutí bol vyliaty opSť na lád (1 500 gramov).6-Amino-2-benzothiazolinethione (27.3 g, 0.15 mol) was dissolved in a solution of potassium hydroxide (9.9 g, 0.15 mol) in water (50 cm 3 ). Dimethylformamide (125 cm 3 ) was added to the reaction mixture with vigorous stirring and, as soon as a homogeneous solution was formed, n-pentyl iodide (29.7 g, 0.15 mol) was added to the reaction mixture in one portion. Vigorous stirring was continued for 30 minutes, then the mixture was poured onto ice (1,500 g) and allowed to stand. After filtration, the crude product was filtered off with suction and, while still wet, was triturated with several portions of petroleum ether (total 300 cm 3 ), the aqueous petroleum ether being decanted each time. The solid residue was dissolved in boiling acetone, water was added to the solution until the first slight turbidity and the mixture was decolorized with activated carbon. The filtrate, after cooling, was poured back onto ice (1,500 grams).
Výťažok produktu s t. t. 33,5 až 36,5 UC činil 30 g (79,4 %).The yield of the product with a melting point of 33.5 to 36.5 ° C was 30 g (79.4%).
Vzdrka pre analýzu bola přečištěná tým spósobom, že látka sa rozpustila za varu v etanole, k roztoku sa přidala voda do prvého zákalu a zmes sa odfarbila aktívnym uhlím. Filtrát po vychladnutí sa vylial na lád, pričom sa počítalo 50 g ladu na 1 g vzorky. Získal sa čistý 6-amíno-2-n-pentyltiobenzotiazol s t. t. 35 až 37 °C.The sample for analysis was purified by dissolving the substance in boiling ethanol, adding water to the solution until it became cloudy, and decolorizing the mixture with activated carbon. The filtrate, after cooling, was poured onto ice, with 50 g of ice per 1 g of sample being used. Pure 6-amino-2-n-pentylthiobenzothiazole with a melting point of 35 to 37 °C was obtained.
Pre:For:
C12H16N2S2 (252,40) vypočítané:C12H16N2S2 (252.40) calculated:
57.10 % C, 6,39 % H, 11,10 % N,57.10% C, 6.39% H, 11.10% N,
25,41 % s, zistené:25.41% with, found:
56,86 % C, 6,31 % H, 11,87 «/o N,56.86% C, 6.31% H, 11.87% N,
25.10 % S.25.10% S.
Příklad 2Example 2
Protikvasinková účinnost zlúčeniny podlá vynálezu (10H mól.dm-3) v porovnaní s účinnoslou 2-merkaptobenzotiazolu (2-MBT)Antifungal activity of the compound according to the invention (10 H mol.dm -3 ) compared to the activity of 2-mercaptobenzothiazole (2-MBT)
ED50 = koncentrácia látky, ktorá brzdí rozmnožovanie kvasinky právě 11a 50 %, oproti kontrole.ED50 = concentration of a substance that inhibits yeast reproduction by 11% compared to the control.
Pre stanevenie protikvasinkovej účinnosti sa použila tekutá syntetická podá s vitamínmi (5 cm3 v skúmavkách), kultivácia statická pri 28 °C. Látky rozpuštěné v dimetylsulfoxide sa dávkovali do pody, potom inokulu. Rozmnožovanie kvasiniek sa sledovalo turbidimetricky, a zo zostrojených rastových kriviek sa matematicko-grafickým výpočtom získali hodnoty EDso.To determine the anti-yeast activity, a liquid synthetic media with vitamins (5 cm 3 in test tubes) was used, static cultivation at 28 °C. Substances dissolved in dimethyl sulfoxide were dosed into the media, then the inoculum. Yeast growth was monitored turbidimetrically, and ED50 values were obtained from the constructed growth curves by mathematical-graphical calculation.
Příklad 3Example 3
Účinnost zlúčeniny pódia vynálezu v porovnaní s účinnosťou 2-merka.ptobenzotiazolu (2-MBT) na rozmnožovanie patogénnych kvasiniekThe efficacy of the compound of the invention compared to the efficacy of 2-mercaptobenzothiazole (2-MBT) on the growth of pathogenic yeasts
Kvasinka EDso (10~e mól. dm”5)Yeast EDso (10~ e mol. dm” 5 )
Deři odčít. Zlúč. podl'a 2-MBT vynálezuDeri subtract. Compound. according to the 2-MBT of the invention
EDso — koncentrácia látky, ktorá brzdí rozmnožovianie kvasinky právě na 50 %, oproti kontrole,EDso — the concentration of a substance that inhibits yeast reproduction by exactly 50%, compared to the control,
C. a. = Candida albicans,C. a. = Candida albicans,
C. c. = Candida ciíerrii,C. c. = Candida cilierrii,
C. g. = Candida guillermondii,Mr. C. = Candida guillermondii,
C. k. = Candida krusei,C. k. = Candida krusei,
C. p. = Candida parapsilosis,C. p. = Candida parapsilosis,
C. r. = Candida robusta,C. r. = Candida robusta,
R. r. = Rhodotorula rubra.R. r. = Rhodotorula rubra.
Protiikvasinková účinnost sa stanovila rovnakým sposobom, ako je to uvedené v příklade 2.Antifungal activity was determined in the same manner as described in Example 2.
Příklad 4Example 4
Účinnost zlúčeniny podlá vynálezu a 2-merkaptobenzotiazolu (2-MBT) ako inhibítorov transformácie kvasinkovitej formy Candida albicant na myceliárnu formuEfficacy of the compound according to the invention and 2-mercaptobenzothiazole (2-MBT) as inhibitors of the transformation of the yeast-like form of Candida albicans into the mycelial form
Pre stanovenie inhibičnej účinnosti na transformáciu kvasinkovitej formy Candida albicans na myceliárnu formu sa použila tekutá podá s N-acetylglukozamínom ako induktorom myceliárneho rastu. Látky sa dávkovali do pody rozpuštěné v dimetylsulfoxide. Inokulácia bola vykonaná výlučné kvaslnkovitou formou, připravenou špeciálnym postupom. Kultivácia bola statická pri 37 °C 48 hodin. Nárast myceliáruej a kvasinkovitej formy bol pozorovaný mikroskopicky.To determine the inhibitory efficacy on the transformation of the yeast form of Candida albicans into the mycelial form, a liquid medium with N-acetylglucosamine as an inducer of mycelial growth was used. The substances were dosed into the medium dissolved in dimethyl sulfoxide. Inoculation was performed exclusively with the yeast form, prepared by a special procedure. Cultivation was static at 37 °C for 48 hours. The growth of the mycelial and yeast forms was observed microscopically.
Kvasinka ID95(Y_M) (mól. dm”3)Yeast ID95( Y _ M) (mol. dm” 3 )
Zlúčenina podlá 2-MBT vynálezuCompound according to the 2-MBT invention
C. a. Pn 10 4.10”5 1.10”3 C. a. Mon 10 4.10” 5 1.10” 3
C. a. 1158/86 2.10”4 >1.10”3 C. a. 1158/86 2.10” 4 >1.10” 3
C. a. — Candida albicans,C. a. — Candida albicans,
ID95(y_M) = koncentrácia látky, ktorá znižuje množstvo myceliárnej formy kvasinky o 95 alebo 95 °/o, vzhladom na kontrolu.ID95(y_ M ) = concentration of substance which reduces the amount of yeast mycelial form by 95 or 95%, relative to the control.
Významný je fakt, že zlúčenina podía vynálezu je novej, doteraz neznámej štruktúry a svojou protikvasinkovou účinnosťou převyšuje 2-merkaptobenzotiazol, účinnú zložku zavedeného preparátu Dermacld.It is significant that the compound according to the invention has a new, previously unknown structure and its anti-yeast activity exceeds 2-mercaptobenzothiazole, the active ingredient of the established preparation Dermacld.
Ďalej významný je fakt, že zlúčenina podlá vynálezu prejavila dobru účinnost proti niektorým patogénnym kvasinkám. Zvlášť významný je fakt, že účinnost (EDso) zlúčeniny podía vynálezu proti patogénnej kvasinke Candida robusta 1069/86, izolovanej zo stolice, po 3 dňoch je ustálená a ďalej sa s časom nemení. Ďalej významný je fakt, že zlúčenina podía vynálezu inhibuje transformáciu kvasinkovitej formy patogénnych dimorfných kvasiniek na mycellárnu formu, čo je důležitou vlastnosťou známých antimykotík.Furthermore, it is significant that the compound according to the invention has shown good activity against some pathogenic yeasts. Particularly significant is the fact that the activity (ED50) of the compound according to the invention against the pathogenic yeast Candida robusta 1069/86, isolated from feces, is stable after 3 days and does not change further with time. Furthermore, it is significant that the compound according to the invention inhibits the transformation of the yeast-like form of pathogenic dimorphic yeasts into the mycelial form, which is an important property of known antifungal agents.
Zlúčeninu podlá vynálezu možno používat ako účinnú zložku protikvasinkových prípriavkov (antimykotík), a to samostatné alebo v zmesi s inými látkami, alebo ako, meziprodukt pre ďalšie syntézy.The compound according to the invention can be used as an active ingredient in anti-yeast preparations (antifungals), either alone or in admixture with other substances, or as an intermediate for further syntheses.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS879176A CS261699B1 (en) | 1987-12-14 | 1987-12-14 | 6-Amino-2-n-pentylthiobenzothiazole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS879176A CS261699B1 (en) | 1987-12-14 | 1987-12-14 | 6-Amino-2-n-pentylthiobenzothiazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS917687A1 CS917687A1 (en) | 1988-07-15 |
| CS261699B1 true CS261699B1 (en) | 1989-02-10 |
Family
ID=5443019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS879176A CS261699B1 (en) | 1987-12-14 | 1987-12-14 | 6-Amino-2-n-pentylthiobenzothiazole |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS261699B1 (en) |
-
1987
- 1987-12-14 CS CS879176A patent/CS261699B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS917687A1 (en) | 1988-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4546113A (en) | Antiprotozoal diamidines | |
| DE1620450C3 (en) | 1 - (2-Hydroxybenzyl) -2-piperazinomethylbenzimidazoles, processes for their preparation and pharmaceuticals containing them | |
| DE2654665B2 (en) | 1-Aryl-2- (1-imidazolyl) -alkyl sulfides, processes for their preparation and antimycotics containing them | |
| US4038405A (en) | Acaricidal trifluoromethyl-1,2,4-triazoles | |
| DE1770269B2 (en) | ImMazol derivatives and herbicidal agents | |
| EP0097014A2 (en) | Triazole antifungal agents | |
| CS261699B1 (en) | 6-Amino-2-n-pentylthiobenzothiazole | |
| US4097599A (en) | Triazoles | |
| DE2225190C3 (en) | New acetophenone oxime derivatives, processes for their preparation and pharmaceutical preparations containing them | |
| FI89595C (en) | Process for the preparation of therapeutically active 2- (thioalkylamino) ethyl-1H-imidazole derivatives | |
| DE934651C (en) | Process for the preparation of tetrasubstituted diaminoalkanes | |
| Benington et al. | Mescaline Analogs. V. p-Dialkylamino-β-phenethylamines and 9-(β-Aminoethyl) julolidine | |
| CS275631B6 (en) | 6-Amino-2- (3-pentylthio) benzothiazole | |
| US2805227A (en) | Substituted nitrosopyrroles and method of preparing the same | |
| US3457314A (en) | Alpha-bromo-cinnamaldehydes and process for preparing them | |
| US4808586A (en) | Substituted benzimidazoles and benzothidiazoles having anti-asthmatic and/or anti-inflammatory activities | |
| US3746705A (en) | Aminoimidazole derivatives | |
| DE2260704C3 (en) | β-Phenyl-β-azolyl-nitroethanes, processes for their preparation and fungicidal and bactericidal agents containing them | |
| DE1955682C3 (en) | 2- [(MethylsulfinylVacetyl] pyridine and process for its preparation | |
| DE1670533C3 (en) | 5-0x0-5,8-dihydropyrido square bracket to 2,3-square bracket to pyrimidine derivatives and process for their preparation | |
| DE68905332T2 (en) | AZOXY - CONNECTION. | |
| US3493566A (en) | 5-benzoylethyl-6-cinnamyl-ideneaminouracils | |
| DE2856792A1 (en) | 1,2,3,4-TETRAHYDOPYDROPYRIDO SQUARE CLIP ON 4 ', 3' TO 4.5 SQUARE BRACKET TO THIAZOLO SQUARE BRACKET ON 3.2-ANGLE BRACKET FOR BENZIMIDAZOLE CONNECTIONS | |
| Reisner et al. | N‐(2‐hydroxy‐5‐chlorobenzylidine)‐anilines and N‐(2‐hydroxy‐5‐chlorobenzyl)‐anilines | |
| HU199431B (en) | Process for producing carbendazim salts, and fungicide comprising such carbendazim salt as active ingredient |